Summary
This Form 8-K filed by UnitedHealth Group Inc. (UNH) on June 6, 2008, primarily reports on the outcomes of its Annual Meeting of Shareholders held on June 5, 2008. The most significant event for investors is the shareholder approval of the material terms for the payment of executive incentive compensation under the Company's 2008 Executive Incentive Plan. This plan establishes specific formulas for funding bonus pools and caps individual compensation, aiming to align executive rewards with company performance. Additionally, the filing details the election of eight directors to the Board and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year 2008. Shareholder proposals regarding advisory votes on executive compensation and performance vesting shares were not approved, indicating shareholder sentiment on those specific matters at the time.
Key Highlights
- 1Shareholders approved the material terms of the 2008 Executive Incentive Plan, which governs executive compensation and includes specific funding formulas and limits.
- 2The 2008 Executive Incentive Plan will be funded by 2% of Company net income for annual awards and 2% of average net income over the performance period for long-term awards.
- 3Maximum cash incentive compensation for any single participant is capped at 25% of their respective bonus pool (annual or long-term).
- 4Eight directors were elected to the Board of Directors.
- 5Deloitte & Touche LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2008.
- 6Shareholder proposals concerning an advisory vote on executive compensation and performance vesting shares were not approved by shareholders.
- 7An amendment to the Company's 1993 Employee Stock Purchase Plan was approved.